Benzenecarboxamide Analogs of Fluoroquinolones (BCFQs). Antibacterial Activity and SAR Studies

Author(s): M. J. Nieto, F. L. Alovero, R. H. Manzo, M. R. Mazzieri

Journal Name: Letters in Drug Design & Discovery

Volume 3 , Issue 2 , 2006


Become EABM
Become Reviewer
Call for Editor

Abstract:

The bioisosteric replacement of the sulfonyl group, in the previously reported benzenesulfonylamidofluoroquinolones (BSFQs), for a carbonyl group was the principle that led to the design of benzenecarboxamide fluoroquinolones (BCFQs). Six new derivatives were prepared and tested against Grampositive and -negative bacteria. As a result, the activity against Staphylococcus aureus of the new series was comparable with norfloxacin or ciprofloxacin but decreased when compared with BSFQs. These findings are significant since the new BCFQs could be incorporated into the selected family of "dual targeting" AMFQs.

Keywords: Fluoroquinolones, SAR, antimicrobial, norfloxacin, ciprofloxacin, benzenecarboxamides

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 3
ISSUE: 2
Year: 2006
Page: [108 - 111]
Pages: 4
DOI: 10.2174/157018006775789702
Price: $65

Article Metrics

PDF: 3